New Treatments for Inflammatory Diseases Sought by Singapore's CREATE Program

The research centers in CREATE will host professors, research investigators, doctoral, and postdoctoral researchers who will form research groups to pursue research programs in areas that are aligned both to Singapore's strategic interest and those of the respective institutions. CREATE entities will have intensive collaboration with Singapore-based universities, polytechnics, laboratories, and research institutes, in cutting-edge research projects and in the attraction of global talent.

A recently announced participant in the CREATE program is the Hebrew University of Jerusalem (Israel). The Hebrew University's research project will focus on cellular and molecular mechanisms of inflammation. The objective of the project is to accelerate the development of diagnostic/prognostic indicators and novel therapeutics for common inflammatory diseases in Asia and elsewhere.

"This collaborative research program will leverage on the existing strengths
of both Hebrew University and National University of Singapore. We see great strategic value in this research, given the increasing prevalence of inflammatory diseases throughout the region. We expect our work to lead to scientific breakthroughs in understanding and developing therapies for inflammatory diseases,” said Dr. Ehud Razin professor of cancer research at the Hebrew University of Jerusalem.

Dr. Tan Chorh Chuan, president of the National University of Singapore, said, "Discovery and evaluation of new treatments for inflammatory diseases continue to be of critical importance. We are pleased to partner with the Hebrew University of Jerusalem under the CREATE program. With strong commitment from both sides, we are confident that this collaboration will have a major impact by addressing important research and medical needs, both in the region and the world.”

Related Links:
Singapore's National Research Foundation's
Hebrew University of Jerusalem
National University of Singapore